PurposeThis study seeks to summarize the relationship between the triglyceride-glucose (TyG) index, a novel and reliable surrogate indicator of insulin resistance, and cancer-associated outcomes throu
¥Statistically significant difference (p<0.01) between 98–99, 00–01 and 02–03 cohort. * There were 31 beneficiaries with unknown race, and 32 with missing urban/rural status. †Including comorbidities